Biomics Biopharma (ASX:BBM) Interest Expense : A$ Mil (TTM As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Biomics Biopharma's interest expense for the six months ended in . 20 was A$ 0.00 Mil. Biomics Biopharma does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Biomics Biopharma's Operating Income for the six months ended in . 20 was A$ 0.00 Mil. Biomics Biopharma's Interest Expense for the six months ended in . 20 was A$ 0.00 Mil. Biomics Biopharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biomics Biopharma Interest Expense Historical Data

The historical data trend for Biomics Biopharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Interest Expense Chart

Biomics Biopharma Annual Data

Trend

Interest Expense

Biomics Biopharma Semi-Annual Data

Interest Expense

Biomics Biopharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Biomics Biopharma (ASX:BBM) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Biomics Biopharma's Interest Expense for the six months ended in . 20 was A$0.00 Mil. Its Operating Income for the six months ended in . 20 was A$0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was A$0.00 Mil.

Biomics Biopharma's Interest Coverage for the quarter that ended in . 20 is calculated as

Biomics Biopharma had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Biomics Biopharma (ASX:BBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Interest Expense

Comparable Companies

ASX:G88 ASX:ELS ASX:BHD ASX:IBX ASX:ZEN ASX:OLI ASX:KPG ASX:CAN ASX:MPW ASX:CQG ASX:OCA

Traded in Other Exchanges

N/A

Address

1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000

Website

http://www.biomics.com

Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines